Hangzhou Biotest Biotech Co.,Ltd. (SHA:688767)
China flag China · Delayed Price · Currency is CNY
38.92
-0.38 (-0.97%)
Apr 30, 2025, 3:00 PM CST

Hangzhou Biotest Biotech Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Cash & Equivalents
1,628-1,9071,9401,368261.17
Upgrade
Short-Term Investments
--10---
Upgrade
Trading Asset Securities
---100.06360.84-
Upgrade
Cash & Short-Term Investments
1,6281,6111,9172,0401,729261.17
Upgrade
Cash Growth
-7.83%-15.98%-6.01%18.02%561.86%1791.45%
Upgrade
Accounts Receivable
67.09-61.8938.82146.9196.26
Upgrade
Other Receivables
1.54-2.81.68.3210.34
Upgrade
Receivables
68.64-64.6840.42155.23106.6
Upgrade
Inventory
75.12-99.32135.2141.792.39
Upgrade
Other Current Assets
49.21-5.3719.67.27.82
Upgrade
Total Current Assets
1,821-2,0872,2352,033467.99
Upgrade
Property, Plant & Equipment
412.89-261.58244.68231.02138.65
Upgrade
Long-Term Investments
8.61-2.844040-
Upgrade
Other Intangible Assets
273.96-208.71213.7120.3520.75
Upgrade
Long-Term Deferred Tax Assets
11.42-14.4413.163.011.52
Upgrade
Long-Term Deferred Charges
--0.110.210.294.86
Upgrade
Other Long-Term Assets
16.33-5.084.54104.130.15
Upgrade
Total Assets
2,544-2,5802,7522,432633.92
Upgrade
Accounts Payable
42.61-56.1588.72224.32110.89
Upgrade
Accrued Expenses
7.73-20.0325.9426.3221.33
Upgrade
Short-Term Debt
1.07-0.590.355.6411.09
Upgrade
Current Portion of Leases
--2.455.12.28-
Upgrade
Current Income Taxes Payable
2.77---3917.34
Upgrade
Current Unearned Revenue
12.95-47.1644.6818.568.93
Upgrade
Other Current Liabilities
41.63-23.056.281.4420.99
Upgrade
Total Current Liabilities
108.76-149.43171.08317.56190.58
Upgrade
Long-Term Leases
---2.194.55-
Upgrade
Long-Term Unearned Revenue
10.75-8.696.431.250.31
Upgrade
Long-Term Deferred Tax Liabilities
--0.711.16--
Upgrade
Other Long-Term Liabilities
---8.43--
Upgrade
Total Liabilities
119.51-158.82189.29323.36190.89
Upgrade
Common Stock
106.67-106.67106.67106.6780
Upgrade
Additional Paid-In Capital
794.6-813.33814.94814.9412.24
Upgrade
Retained Earnings
1,552-1,5101,6381,185351.2
Upgrade
Treasury Stock
-31.61--14.76---
Upgrade
Comprehensive Income & Other
1.02--0.361.210.70.7
Upgrade
Total Common Equity
2,4222,3762,4152,5612,107444.14
Upgrade
Minority Interest
1.79-5.511.041.05-1.11
Upgrade
Shareholders' Equity
2,4242,3792,4212,5622,108443.02
Upgrade
Total Liabilities & Equity
2,544-2,5802,7522,432633.92
Upgrade
Total Debt
1.070.743.047.6412.4711.09
Upgrade
Net Cash (Debt)
1,6261,6101,9142,0321,716250.08
Upgrade
Net Cash Growth
-7.78%-15.88%-5.81%18.43%586.22%-
Upgrade
Net Cash Per Share
15.2915.3117.9619.0519.803.13
Upgrade
Filing Date Shares Outstanding
109.16105.81104.56106.67106.6780
Upgrade
Total Common Shares Outstanding
109.16104.52106.22106.67106.6780
Upgrade
Working Capital
1,712-1,9372,0641,715277.4
Upgrade
Book Value Per Share
22.1922.7322.7424.0119.755.55
Upgrade
Tangible Book Value
2,1482,1712,2072,3482,087423.39
Upgrade
Tangible Book Value Per Share
19.6820.7820.7722.0119.565.29
Upgrade
Buildings
--193.65194.71189.1337.09
Upgrade
Machinery
--90.9281.6166.1937.92
Upgrade
Construction In Progress
--39.659.85-88.61
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.